USFDA completes inspection at facility of Granules India’s arm

22 Aug 2019

US Food and Drug Administration (USFDA) has completed inspection of the facility of Granules India’s wholly owned foreign subsidiary -- Granules Pharmaceuticals, Inc., US on August 21, 2019 with two minor observations.

This is a pre-approval inspection for seven products filed from this facility. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Related Granules India Ltd. Links:

Granules India Share Price

363.65 -0.75 (-0.21%) Mar 04, 18:59
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 618.65
Dr. Reddys Lab 4574.30
Lupin 1048.15
Piramal Enterprises 1956.90
Cadila Healthcare 449.00
View more..
Sensex vs Granules India
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback